tetano
Editor, Senior Moderator
Respir Med
. 2021 Jun 21;186:106516.
doi: 10.1016/j.rmed.2021.106516. Online ahead of print.
Respiratory care for the critical patients with 2019 novel coronavirus
Yao-Chen Wang[SUP] 1 [/SUP], Min-Chi Lu[SUP] 2 [/SUP], Shun-Fa Yang[SUP] 3 [/SUP], Mauo-Ying Bien[SUP] 4 [/SUP], Yi-Fang Chen[SUP] 5 [/SUP], Yia-Ting Li[SUP] 6 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observational studies were reviewed. Corresponding respiratory therapy regarding different stages of infection is proposed. Infection control principles and respiratory strategies including oxygen therapy, non-invasive respiratory support (NIRS), intubation evaluation, equipment preparation, ventilator settings, special maneuvers comprise of the prone position (PP), recruitment maneuver (RM), extracorporeal membrane oxygenation (ECMO), weaning and extubation are summarized. Respiratory equipment and device disinfection recommendations are worked up. We expect this review article could be used as a reference by healthcare workers in patient care while minimizing the risk of environmental contamination.
Keywords: 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care.
. 2021 Jun 21;186:106516.
doi: 10.1016/j.rmed.2021.106516. Online ahead of print.
Respiratory care for the critical patients with 2019 novel coronavirus
Yao-Chen Wang[SUP] 1 [/SUP], Min-Chi Lu[SUP] 2 [/SUP], Shun-Fa Yang[SUP] 3 [/SUP], Mauo-Ying Bien[SUP] 4 [/SUP], Yi-Fang Chen[SUP] 5 [/SUP], Yia-Ting Li[SUP] 6 [/SUP]
Affiliations
- PMID: 34218168
- DOI: 10.1016/j.rmed.2021.106516
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observational studies were reviewed. Corresponding respiratory therapy regarding different stages of infection is proposed. Infection control principles and respiratory strategies including oxygen therapy, non-invasive respiratory support (NIRS), intubation evaluation, equipment preparation, ventilator settings, special maneuvers comprise of the prone position (PP), recruitment maneuver (RM), extracorporeal membrane oxygenation (ECMO), weaning and extubation are summarized. Respiratory equipment and device disinfection recommendations are worked up. We expect this review article could be used as a reference by healthcare workers in patient care while minimizing the risk of environmental contamination.
Keywords: 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care.